Skip to main content

Alexandre de Germay

Equibles does not estimate personal net worth.

Get an email with a short summary when Pfizer Inc publishes a filing, an earnings call transcript or a press release.

Get PFE alerts

About Alexandre de Germay

Pfizer Inc reported in an 8-K filed December 12, 2023 that Alexandre de Germay was appointed Chief International Commercial Officer, Executive Vice President, effective December 15, 2023. Alexandre de Germay has spoken on 1 earnings call across 1 company, most recently for Pfizer Inc on February 3, 2026. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Pfizer Inc includes A. Bourla (CEO), I. Read (Chairman), Cecile Guegan (CFO) and 7 others.

“the Pfizer International Commercial Division, which will be led by Alexandre de Germay, who will join Pfizer as Chief International Commercial Officer, Executive Vice President, and will report to Dr. Bourla.”
Pfizer Inc Form 8-K, filed December 12, 2023 · Read the filing

Alexandre de Germay on recent calls

“What's really interesting in this category is actually the size of the market ex-US, projected to be 150 billion, and 40% of that is actually ex-US. There are two things that are really interesting in this category that are unique and that reinforce the potential of this asset.”
Other, Pfizer Inc Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Pfizer Inc

Recent activity